These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37466178)

  • 1. Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials.
    Noorani T; Bedi G; Muthukumaraswamy S
    Psychol Med; 2023 Oct; 53(13):5892-5901. PubMed ID: 37466178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.
    Aday JS; Heifets BD; Pratscher SD; Bradley E; Rosen R; Woolley JD
    Psychopharmacology (Berl); 2022 Jun; 239(6):1989-2010. PubMed ID: 35359159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology.
    Miceli McMillan R; Fernandez AV
    Aust N Z J Psychiatry; 2023 Jun; 57(6):783-788. PubMed ID: 36384307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectancy in placebo-controlled trials of psychedelics: if so, so what?
    Butler M; Jelen L; Rucker J
    Psychopharmacology (Berl); 2022 Oct; 239(10):3047-3055. PubMed ID: 36063208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for establishing best practices and gold standards in psychedelic medicine.
    Feduccia A; Agin-Liebes G; Price CM; Grinsell N; Paradise S; Rabin DM
    J Affect Disord; 2023 Jul; 332():47-54. PubMed ID: 37003433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS; Parker SE; Weleff J
    Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.
    Kious B; Schwartz Z; Lewis B
    J Psychopharmacol; 2023 Jan; 37(1):45-48. PubMed ID: 36377548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy.
    Gukasyan N; Nayak SM
    Transcult Psychiatry; 2022 Oct; 59(5):652-664. PubMed ID: 33499762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing placebo: Lessons from psychedelic science.
    Pronovost-Morgan C; Hartogsohn I; Ramaekers JG
    J Psychopharmacol; 2023 Sep; 37(9):866-875. PubMed ID: 37392012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation.
    Reynolds LM; Akroyd A; Sundram F; Stack A; Muthukumaraswamy S; Evans WJ
    Int J Environ Res Public Health; 2021 Aug; 18(15):. PubMed ID: 34360453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).
    Emerson A; Ponté L; Jerome L; Doblin R
    J Psychoactive Drugs; 2014; 46(1):27-36. PubMed ID: 24830183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelics and the essential importance of context.
    Carhart-Harris RL; Roseman L; Haijen E; Erritzoe D; Watts R; Branchi I; Kaelen M
    J Psychopharmacol; 2018 Jul; 32(7):725-731. PubMed ID: 29446697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic injustice: should bioethics tune in to the voices of psychedelic-using communities?
    Miceli McMillan R
    Med Humanit; 2022 Sep; 48(3):269-272. PubMed ID: 35074926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
    Palitsky R; Kaplan DM; Peacock C; Zarrabi AJ; Maples-Keller JL; Grant GH; Dunlop BW; Raison CL
    JAMA Psychiatry; 2023 Jul; 80(7):743-749. PubMed ID: 37256584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture.
    Hartogsohn I
    Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis and psychedelics: Historical entanglements and contemporary contrasts.
    Friesen P
    Transcult Psychiatry; 2022 Oct; 59(5):592-609. PubMed ID: 36300247
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.